Use of proton pump inhibitors and risk of severe COVID-19: A case-control study in United States Medicare beneficiaries.
Mosholder AD, Izurieta HS, Zhang R, Shangguan S, Lu Y, Akhtar S, Wernecke M, He J, Chillarige Y, Feng Y, Avagyan A, Leishear K, Forshee RA, MaCurdy TE, Kelman JA, Graham DJ.
Mosholder AD, et al. Among authors: kelman ja.
Pharmacotherapy. 2024 Oct;44(10):803-810. doi: 10.1002/phar.4614. Epub 2024 Oct 18.
Pharmacotherapy. 2024.
PMID: 39425479